EMPLOYMENT AGREEMENTEmployment Agreement • June 10th, 2010 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 10th, 2010 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is made effective as of June 4, 2010 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Gene Hsiao (the “Executive” and together with the Company, the “Parties”).
INCENTIVE OPTION AGREEMENT BETWEEN TAN Shaohua AND Qu Hongwei Date: December 7, 2009Incentive Option Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • Virgin Islands
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionTHIS INCENTIVE OPTION AGREEMENT (this "Agreement") is made on December 7, 2009 by and between TAN Shaohua, a Singapore citizen (the "Grantor") and Qu Hongwei ("Grantee").
SECURITIES ESCROW AND PLEDGE AGREEMENTSecurities Escrow and Pledge Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionThis SECURITIES ESCROW AND PLEDGE AGREEMENT (this “Agreement”), dated as of January 5, 2010, is entered into by and among Link Resources, Inc., a Nevada corporation (the “Company”), Euro Pacific Capital, Inc., as representative of the Investors (the “Investor Representative”), Glory Period Limited, a company organized in the British Virgin Islands (the “Principal Stockholder”), and Escrow, LLC (the “Escrow Agent”). Capitalized terms used but not defined herein shall have the meanings set forth in the Purchase Agreement (as defined below).
SHARE EXCHANGE AGREEMENTShare Exchange Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionThis SHARE EXCHANGE AGREEMENT (this “Agreement”) is entered into as of this 5th day of January, 2010, by and between Link Resources, Inc., a Nevada corporation (hereinafter referred to as “Link”), Chance High International Limited, a British Virgin Islands business company (“Chance High”) and the shareholders of Chance High listed on Schedule A hereto (collectively, the “Chance High Shareholders”).
FORM OF INDEPENDENT DIRECTOR AGREEMENTIndependent Director Agreement • July 13th, 2010 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJuly 13th, 2010 Company Industry JurisdictionTHIS INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made as of the _____ day of July, 2010 and is by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and _________(the “Director”).
AMENDMENT AND AGREEMENTAmendment and Agreement • July 6th, 2010 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2010 Company Industry JurisdictionThis AMENDMENT AND AGREEMENT (this “Agreement”) is entered into effective for all purposes as of June 30, 2010 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
SUBSCRIPTION AGREEMENTSubscription Agreement • January 25th, 2011 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 25th, 2011 Company Industry JurisdictionThis SUBSCRIPTION AGREEMENT (this “Agreement”) made as of this 21st day of January, 2011 for the benefit of Bohai Pharmaceuticals Group, Inc., a company incorporated under the laws of Nevada, USA (the “Company”), having its principal place of business at c/o Yantai Bohai Pharmaceuticals Group Co. Ltd., No. 9 Daxin Road, Zhifu District, Yantai, Shandong Province, China, by the person or entity listed on the signature page hereto under the heading “Subscriber” (the “Subscriber”).
FIFTH AMENDMENT TO CONVERTIBLE NOTESConvertible Notes • April 22nd, 2014 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 22nd, 2014 Company Industry JurisdictionThis FIFTH AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of April 21, 2014 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
ContractSenior Convertible Promissory Note • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionTHIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.
Three Parties Fund Escrow AgreementThree Parties Fund Escrow Agreement • May 11th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations
Contract Type FiledMay 11th, 2012 Company IndustryParty A is a Chinese legal person or other entity which was incorporated in accordance with laws and regulations of the People’s Republic of China (the “PRC”), which has necessary civil ability and capacity to execute and perform this Agreement, and to undertake the civil liability independently. Party A has obtained all the necessary and legitimate permit and authority to execute this Agreement. Party A guarantees the legitimacy of source of the fund;
TERMINATION AGREEMENTTermination Agreement • April 1st, 2011 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 1st, 2011 Company Industry JurisdictionThis TERMINATION AGREEMENT (this “Agreement”) is made as of the 30th day of March, 2011 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • January 5th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 5th, 2012 Company Industry JurisdictionThis AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of December 31, 2011 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated January 5, 2010, is between Link Resources Inc., a Nevada corporation (the “Company”), and each purchaser identified on Schedule A hereto (each, including their respective successors and assigns, an “Investor” and collectively, the “Investors”).
ContractWarrant Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores
Contract Type FiledJanuary 11th, 2010 Company IndustryNEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.
FOURTH AMENDMENT TO CONVERTIBLE NOTESConvertible Notes • December 6th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 6th, 2012 Company Industry JurisdictionThis FOURTH AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of December 6, 2012 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
yantai-01-2010-0018 LAND USE RIGHTS PURCHASE CONTRACTLand Use Rights Purchase Contract • September 28th, 2010 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 28th, 2010 Company IndustryUpon the approval of renewal of the land use right, the Grantee or its successor or assignee shall comply with requirements set forth in the applicable law, enter into a land use right purchase or lease agreement, as the case may be, and make payments for the applicable purchase price or rent.
MINERAL LEASE AGREEMENTMineral Lease Agreement • August 20th, 2008 • Link Resources Inc.
Contract Type FiledAugust 20th, 2008 CompanyTimberwolf Minerals, LTD (Lessor) leases to Link Resources Inc., (Lessee) the unpatented mining claims attached as Exhibit “A” (referred to as the Property) located in Section 20 , Township 30 North, Range 39 East, Mt. Diablo Meridian in Pershing County, Nevada, USA, subject to the following conditions:
Supplemental Agreement to the Three Parties Fund Escrow AgreementSupplemental Agreement • May 11th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations
Contract Type FiledMay 11th, 2012 Company Industry
LINK RESOURCES, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • January 11th, 2010 • Link Resources Inc. • Gold and silver ores
Contract Type FiledJanuary 11th, 2010 Company IndustryThis Warrant is being issued pursuant to a Securities Purchase Agreement, dated January 5, 2009 (the “SPA”), by and between the Company, the Initial Holder and the other parties thereto.
AGREEMENT AND PLAN OF MERGERMerger Agreement • February 4th, 2010 • Bohai Pharmaceuticals Group, Inc. • Gold and silver ores • Nevada
Contract Type FiledFebruary 4th, 2010 Company Industry JurisdictionTHEREFORE, in consideration of the mutual agreements and covenants set forth herein, the parties hereto do hereby agree to merge on the terms and conditions herein provided, as follows:
SECOND AMENDMENT TO CONVERTIBLE NOTESConvertible Notes • May 15th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2012 Company Industry JurisdictionThis SECOND AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of May 15, 2012 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
CLOSING ESCROW AGREEMENTClosing Escrow Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionThis CLOSING ESCROW AGREEMENT, dated as of December 10, 2009 (this “Agreement”), is entered into by and among Link Resources, Inc., a Nevada corporation (the “Company”), Euro Pacific Capital, Inc. (the “Placement Agent”) and Escrow, LLC, with its principal offices located at 215 Mockingbird Lane, Warrenton, Virginia 20186 (the “Escrow Agent”). The Placement Agent and the Company are sometimes each referred to herein as an “Escrowing Party” and collectively, the “Escrowing Parties.”
JANGBO CHI SHULIAN WANGShare Transfer Agreement • August 10th, 2011 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2011 Company IndustryThis Share Transfer Agreement (this “Agreement”) is entered into by and among the following parties on August 8, 2011 in Beijing, PRC.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 11th, 2010 • Link Resources Inc. • Gold and silver ores • New York
Contract Type FiledJanuary 11th, 2010 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated January 5, 2010, is between Link Resources Inc., a Nevada corporation (the “Company”), and each purchaser identified on Schedule A hereto (each, including their respective successors and assigns, an “Investor” and collectively, the “Investors”) and, with respect to certain sections hereof, Euro Pacific Capital, Inc. (the “Lead Placement Agent”).
Unofficial English Translation of Intangible Assets Transfer AgreementIntangible Assets Transfer Agreement • December 14th, 2010 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 14th, 2010 Company IndustryWhereas, based on thorough negotiations between Party A and Party B, Party A (Shandong Daxin Microbiology Pharmaceutical Industry Co., Ltd) agrees to transfer all of its rights and title in and to fourteen (14) Drug Approval Numbers (the “DANs”) for fourteen (14) medicines that were previously issued by Shandong Drug Administration to Party B (Yantai Bohai Pharmaceutical Group Co., Ltd). Both Parties hereby make the following agreements:
THIRD AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • June 28th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 28th, 2012 Company Industry JurisdictionThis THIRD AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of June 27, 2012 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).